22.03.2017
Carl Zeiss Meditec AG DE0005313704
DGAP-Adhoc: Carl Zeiss Meditec AG successfully completes capital increase
DGAP-Ad-hoc: Carl Zeiss Meditec AG / Key word(s): Capital Increase/Corporate
Action
Carl Zeiss Meditec AG successfully completes capital increase
22-March-2017 / 08:12 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR, transmitted by
DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO
THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION
IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.
Carl Zeiss Meditec AG successfully completes capital increase
JENA, 22 March 2017
Carl Zeiss Meditec AG raises proceeds of around EUR 317 million from the
capital increase.
Carl Zeiss Meditec AG (ISIN: DE0005313704), (the "Company") has successfully
concluded the capital increase announced yesterday. The order book was
closed early due to the strong demand.
A total of 8,130,960 new shares were placed at a price of EUR 38.94 per
share. The gross proceeds to the Company from the capital increase amount to
approximately EUR 317 million. The new shares shall be admitted to trading
on the regulated market of the Frankfurt Stock Exchange, with simultaneous
admission to the sub-segment of the regulated market with additional
post-admission obligations (Prime Standard). The first trading day of the
new shares is scheduled for 27 March 2017.
Contact for investors and press
Sebastian Frericks
Director Investor Relations Carl Zeiss Meditec AG
Phone: +49 (0)3641 220-116
Email: [email protected]
www.zeiss.de/presse
Forward-Looking Statements
This news release may contain forward-looking statements based on current
assumptions and forecasts made by Carl Zeiss Meditec AG management. Various
known and unknown risks, uncertainties and other factors could lead to
material differences between the actual future results, financial situation,
development or performance of the company and the estimates given here. The
company assumes no liability whatsoever to update these forward-looking
statements or to confirm them to future events or developments.
Notice
This publication does not constitute a public offer of securities in
Germany. It is not for publication or distribution, directly or indirectly,
in or into the United States of America, Canada, Australia, or any other
jurisdiction in which the distribution or release would be unlawful. This
publication does not constitute a prospectus, an offer to sell securities,
or a solicitation of an offer to buy securities, in the United States of
America or in any other jurisdiction to any person to whom it is unlawful to
make such offer or solicitation in such jurisdiction. Securities may not be
offered or sold in the United States of America absent registration or an
exemption from registration under the U.S. Securities Act of 1933, as
amended (the 'Securities Act'). The securities of Carl Zeiss Meditec AG
described herein have not been and will not be registered under the
Securities Act, or the laws of any state or territory of the United States,
and may not be offered or sold within the United States of America, except
pursuant to an exemption from, or in a transaction not subject to, the
registration requirements of the Securities Act and applicable state laws.
Carl Zeiss Meditec AG does not intend to register any portion of the
offering in the United States of America or conduct a public offering of
securities in the United States of America.
---------------------------------------------------------------------------
22-March-2017 CET/CEST The DGAP Distribution Services include Regulatory
Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: Carl Zeiss Meditec AG
Göschwitzer Str. 51-52
07745 Jena
Germany
Phone: +49 (0)3641 220-0
Fax: +49 (0)3641 220-112
E-mail: [email protected],[email protected]
Internet: www.meditec.zeiss.de
ISIN: DE0005313704
WKN: 531370
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated
Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover,
Munich, Stuttgart, Tradegate Exchange
End of Announcement DGAP News Service
---------------------------------------------------------------------------
556741 22-March-2017 CET/CEST
|
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu
Carl Zeiss Meditec AG ISIN: DE0005313704 können Sie bei EQS abrufen
Medtech , 531370 , AFX , XETR:AFX